GTBPVSNCI• 28 Days (Normalized)
GTBP vs NCI (GT Biopharma Inc. vs Neo-Concept International Group Holdings Limited)
Showing Closing Date Range from Sep 4 to Oct 2, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
GTBP Performance $6.1
+2431.12%
GT Biopharma Inc.
Normalized Baseline0.00%
NCI Performance $0.86
-93.63%
Neo-Concept International Group Holdings Limited
Normalized Baseline0.00%
Alpha Spread Margin GTBP LEADS
+2524.75 pts
GTBP outperforming by 2524.75 percentage points
GTBPNCI
Spread Trajectory28 Days (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
GTBP NCI
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(19 dates)
| Date | GTBP Price | GTBP Gain (%) | NCI Price | NCI Gain (%) | Spread |
|---|---|---|---|---|---|
| Oct 02, 2026 | $6.10 | +2431.12% | $0.86 | -93.63% | +2524.75% |
| Oct 01, 2026 | $- | $1.06 | -92.17% | - | |
| Sep 30, 2026 | $- | $1.26 | -90.69% | - | |
| Sep 29, 2026 | $6.88 | +2752.70% | $1.26 | -90.69% | +2843.39% |
| Sep 28, 2026 | $6.80 | +2721.58% | $2.38 | -82.42% | +2804.00% |
| Sep 25, 2026 | $6.89 | +2758.92% | $- | - | |
| Sep 24, 2026 | $6.83 | +2734.02% | $- | - | |
| Sep 23, 2026 | $7.10 | +2846.06% | $14.60 | +7.83% | +2838.23% |
| Sep 21, 2026 | $7.18 | +2879.25% | $13.63 | +0.66% | +2878.59% |
| Sep 18, 2026 | $7.16 | +2870.95% | $13.90 | +2.66% | +2868.29% |
| Sep 17, 2026 | $7.49 | +3007.88% | $13.29 | -1.85% | +3009.73% |
| Sep 16, 2026 | $7.81 | +3140.66% | $13.33 | -1.59% | +3142.25% |
| Sep 15, 2026 | $9.00 | +3634.44% | $12.94 | -4.43% | +3638.87% |
| Sep 14, 2026 | $11.63 | +4725.73% | $12.92 | -4.58% | +4730.31% |
| Sep 11, 2026 | $8.61 | +3472.61% | $12.97 | -4.21% | +3476.82% |
Page 1 of 2